Activation of TAK1 by MYD88 L265P drives malignant B-cell Growth in non-Hodgkin lymphoma.
Ansell SM, Hodge LS, Secreto FJ, Manske M, Braggio E, Price-Troska T, Ziesmer S, Li Y, Johnson SH, Hart SN, Kocher JP, Vasmatzis G, Chanan-Kahn A, Gertz M, Fonseca R, Dogan A, Cerhan JR, Novak AJ.
Ansell SM, et al.
Blood Cancer J. 2014 Feb 14;4(2):e183. doi: 10.1038/bcj.2014.4.
Blood Cancer J. 2014.
PMID: 24531446
Free PMC article.